Anesth Analg 2003;96:923-928
© 2003 International Anesthesia Research Society
CARDIOVASCULAR ANESTHESIA
Single-Dose Tranexamic Acid Reduces Postoperative Bleeding After Coronary Surgery in Patients Treated with Aspirin Until Surgery
Hilde Pleym, MD*,
Roar Stenseth, MD PhD*,
Alexander Wahba, MD PhD ,
Lise Bjella, MD*,
Asbjørn Karevold, MD , and
Ola Dale, MD PhD*,
Departments of *Anesthesiology and
Cardiothoracic Surgery, St. Olav University Hospital, Trondheim, Norway; and
Department of Anaesthesia and Medical Imaging, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway
Address correspondence and reprint requests to Hilde Pleym, MD, St. Elisabeth Heart Clinic, Hans Nissens Gate 3, N-7018 Trondheim, Norway. Address e-mail to Hilde.Pleym{at}stolav.no
Tranexamic acid reduces postoperative bleeding after coronary artery bypass grafting. We evaluated the effects of a single dose of tranexamic acid given immediately before cardiopulmonary bypass (CPB) in patients treated with aspirin until the day before surgery. The study was a prospective, randomized, double-blinded, placebo-controlled, parallel-group trial. Eighty patients were included and divided into two groups: one group received tranexamic acid 30 mg/kg, and one group received placebo (0.9% NaCl) as a bolus injection before CPB. Postoperative blood loss was recorded for 16 h. Transfusions of blood products were recorded for the whole hospital stay. Transfusions of packed red cells were given when the hematocrit value was less than 20% during CPB and less than 25% after surgery. The patients in the tranexamic acid group had significantly less postoperative bleeding compared with the patients in the placebo group (mean [SD]) (475 [274] mL versus 713 [243] mL; P < 0.001). An effective inhibition of fibrinolysis was found in patients receiving tranexamic acid. Tranexamic acid reduces postoperative bleeding in coronary artery bypass grafting patients treated with aspirin until the day before surgery.
IMPLICATIONS: Continuation of aspirin medication until the day before coronary artery bypass grafting may increase postoperative bleeding. The administration of a single dose of tranexamic acid (30 mg/kg) immediately before cardiopulmonary bypass significantly reduced postoperative bleeding and inhibited fibrinolysis in these patients.
This article has been cited by other articles:

|
 |

|
 |
 
D. R. McIlroy, P. S. Myles, L. E. Phillips, and J. A. Smith
Antifibrinolytics in cardiac surgical patients receiving aspirin: a systematic review and meta-analysis
Br. J. Anaesth.,
February 1, 2009;
102(2):
168 - 178.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. R. Bridges
Valid Comparisons of Antifibrinolytic Agents Used in Cardiac Surgery
Circulation,
June 5, 2007;
115(22):
2790 - 2792.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. R. Brown, N. J.O. Birkmeyer, and G. T. O'Connor
Meta-Analysis Comparing the Effectiveness and Adverse Outcomes of Antifibrinolytic Agents in Cardiac Surgery
Circulation,
June 5, 2007;
115(22):
2801 - 2813.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
The Society of Thoracic Surgeons Blood Conservatio, V. A. Ferraris, S. P. Ferraris, S. P. Saha, E. A. Hessel II, C. K. Haan, B. D. Royston, C. R. Bridges, R. S.D. Higgins, G. Despotis, et al.
Perioperative Blood Transfusion and Blood Conservation in Cardiac Surgery: The Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists Clinical Practice Guideline
Ann. Thorac. Surg.,
May 1, 2007;
83(5_Supplement):
S27 - S86.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Pleym, V. Videm, A. Wahba, A. Asberg, T. Amundsen, L. Bjella, O. Dale, and R. Stenseth
Heparin resistance and increased platelet activation in coronary surgery patients treated with enoxaparin preoperatively.
Eur. J. Cardiothorac. Surg.,
June 1, 2006;
29(6):
933 - 940.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Thiagarajamurthy, A. Levine, and J. Dunning
Does prophylactic tranexamic acid safely reduce bleeding without increasing thrombotic complications in patients undergoing cardiac surgery?
Interactive CardioVascular and Thoracic Surgery,
September 1, 2004;
3(3):
489 - 494.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Andreasen and C. Nielsen
Prophylactic tranexamic acid in elective, primary coronary artery bypass surgery using cardiopulmonary bypass
Eur. J. Cardiothorac. Surg.,
August 1, 2004;
26(2):
311 - 317.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Bombeli and D. R. Spahn
Updates in perioperative coagulation: physiology and management of thromboembolism and haemorrhage
Br. J. Anaesth.,
August 1, 2004;
93(2):
275 - 287.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Pleym, R. Stenseth, A. Wahba, L. Bjella, A. Tromsdal, A. Karevold, and O. Dale
Prophylactic Treatment with Desmopressin Does Not Reduce Postoperative Bleeding After Coronary Surgery in Patients Treated with Aspirin Before Surgery
Anesth. Analg.,
March 1, 2004;
98(3):
578 - 584.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Casati, H. Pleym, R. Stenseth, A. Wahba, L. Bjella, A. Karevold, and O. Dale
Tranexamic Acid and Coronary Surgery * Response
Anesth. Analg.,
January 1, 2004;
98(1):
275 - 275.
[Full Text]
[PDF]
|
 |
|
|